Course Directors: David H. Adams, MD, FACC; Steven F. Bolling, MD, MACC; Robert O. Bonow, MD, FACC; Howard C. Herrmann, MD, FACC

Heart disease is the leading cause of death in the United States. Valvular heart disease (VHD) affects more than five million individuals just in this country. VHD can be congenital or acquired, and patients may or may not exhibit symptoms. Although there are national guidelines regarding management of VHD, controversies in care in the areas of advanced technology and medicine demand that collaborative methods be created for diagnosis and strategic medical, surgical and interventional management.

Thursday October 20, 2016

• 3:50 p.m. Low Risk Trials: Promise or Peril - Ani Anyanwu, MD

Friday October 21, 2016

• 7:42 a.m. Degenerative Mitral Valve Disease: From Analysis to Reconstruction - David H. Adams, MD

• 9:04 a.m. Are We Ready for Reference Surgeons and Centers: AATS Consensus Guidelines - Ani Anyanwu, MD

• 9:16 a.m. Case Presentations - Ani Anyanwu, MD

• 10:39 a.m. Surgical Strategies in Ischemic MR - Ani Anyanwu, MD

• 11:03 a.m. Case Presentations - Ani Anyanwu, MD

• 11:30 a.m. Honored Lecture, Moderator - David H. Adams, MD

• 1:35 p.m. Ischemic MR Trials: Limitations - Ani Anyanwu, MD

• 1:45 p.m. Moderated Discussion - Ani Anyanwu, MD

• 2:05 p.m. Concomitant Tricuspid Valve Repair Trial: Limitations? - David H. Adams, MD

• 2:15 p.m. Moderated Discussion - David H. Adams, MD

• 2:35 p.m. Surgical Management - David H. Adams, MD

• 2:45 p.m. Moderated Discussion - David H. Adams, MD

• 3:50 p.m. Re-repair of the Mitral Valve - David H. Adams, MD

• 4:05 p.m. Case Presentations - David H. Adams, MD

• 5:15 p.m. Emerging Chordae Devices for Trans-apical Mitral Valve Repair - David H. Adams, MD

• 5:40 p.m. Moderated Discussion - David H. Adams, MD

Saturday October 22, 2016

• 9:30 a.m. Carcinoid Valve Disease - David H. Adams, MD